StonvexLoading…
StonvexStonvexStonvexCore line items from MNKD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $90.17M | $348.97M | $237.01M | $154.88M |
Operating Income | $-1.67M | $38.80M | $46.49M | $27.59M |
Net Income | $-16.62M | $5.86M | $21.81M | $668.00K |
EPS (Diluted) | $-0.05 | $0.02 | $0.07 | $0.04 |
Total Assets | $744.40M | $792.18M | $494.64M | $411.70M |
Total Liabilities | $803.60M | $843.20M | $539.19M | $466.74M |
Cash & Equivalents | $52.83M | $74.88M | $127.39M | $57.01M |
Free Cash Flow OCF − CapEx | $-7.25M | $13.69M | $23.64M | $1.13M |
Shares Outstanding | 308.91M | 307.83M | 307.03M | 306.33M |